Key facts
as of Oct 2026- Operator of a clinical intelligence company intended to offer intelligent prior authorization by aligning physicians and health plans.
- Cohere Health is valued at approximately $750.0M as of Oct 2026, set at its Series C, May 2025; nothing has traded since, per Private Market View’s mark.
- It has raised $213.1M across 5 recorded rounds; the latest was Later Stage VC ($90.0M) in May 2025.
- Notable investors include Temasek Holdings, Polaris Partners, Flare Capital Partners, Deerfield Management, Longitude Capital — 7 tracked in total.
- Status: Privately Held (backing).
Private Market View mark
LOW confidence$750.0M
Valued at $750.0M at its Series C, May 2025. Nothing has traded since.
Free account
More of this page with a free account
- ·Post-money valuations for all 5 rounds
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Cohere Health
Create free account
No card required
Funding rounds
5 roundsMay 2025Series C$90.0M▮
Feb 2024Series B$52.0M▮
Jul 2022Debt - General$15.0M▮
Jul 2022Series B$36.1M▮
Sep 2020Series A$20.0M▮
About Cohere Health
Operator of a clinical intelligence company intended to offer intelligent prior authorization by aligning physicians and health plans. The company's intelligent prior authorization is configurable for each health plan's needs and can be implemented as a fully outsourced utilization management service, providing patients and doctors with end-to-end authorization automation to digitize the process and guide care across the entire patient journey.
- Sector
- Healthcare
- HQ
- Portsmouth, NH, United States
- Founded
- 2019
- Employees
- 908
- Website
- coherehealth.com/
- Ownership
- Privately Held (backing)